Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Indonesian Journal of Medicine Journal of Health Policy and Management
Wijayanto, Masromi Hendria
Unknown Affiliation
Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Meta-Analysis of the Effect of Policy Lockdown on Anxiety in Adults Rohmah, Isna Nur; Sekar, Fauzia Ichlasul; Samudera, Galang Aji; Anasulfalah, Hakim; Ningsih, Hepti Widia; Paramastri, Izdihar Azzah; Wijayanto, Masromi Hendria; Arianty, Meike; Putra, Muhammad Dudayev Caesar; Husein, Muhammad Fajar
Journal of Health Policy and Management Vol. 6 No. 2 (2021)
Publisher : Masters Program in Public Health, Universitas Sebelas Maret, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (33.512 KB)

Abstract

Background: On March 11, 2020, the World Health Organization (WHO) has declared an outbreak of a new coronavirus (COVID-19) as a global pandemic. In responding to the threat of the COVID-19 virus pandemic, policymakers have implemented a policy lockdown that can cause psychological distress, one of which is anxiety. This study aims to examine the effect of the policy lockdown on anxiety in adults using a meta-analysis.Subjects and Method: Meta-analysis was performed by searching for articles from the database, namely PubMed, Google Scholar, Sci­ence Direct, Scopus, and Crossref. The key­words used are "Anxiety" AND "Adult" AND "COVID-19" OR "SARS-CoV-2" AND "Lock­down" OR "Movement Restriction" OR "qua­ran­tine" OR "shutdown". The inclusion criteria in this study were full-text articles with a cross-sectional design, in English, published in the period 2019-2021. Analysis of the article using RevMan 5.3.Results: Four articles were analyzed. The results of the meta-analysis showed that anxiety in adults with the implementation of the policy lockdown was 1.94 times more at risk than those who did not implement the policy lockdown, but it was not significant in incre­asing anxiety in adults (aOR= 1.94; 95% CI= 0.79 to 4.74; p= 0.150).Conclusion: Anxiety in adults with the imple­mentation of the policy is lockdown more at risk than those who have not implemented the policy lockdown, but it is not significant in increasing anxiety in adults. Keywords: Anxiety, lockdown, covid-19 Correspondence: Isna Nur Rohmah. Health Polytechnic, Minis­try of Health, Semarang. Jl. Tirto Agung, Peda­langan, Banyumanik, Semarang City, Central Java 50268. Email: isnanr28@gmail.com. Mobile: +6281327215685Journal of Health Policy and Management (2021), 06(02): 139-147https://doi.org/10.26911/thejhpm.2021.06.02.06 
Meta-Analysis the Effectiveness of Ivermectin Use on the Length of Stay in Inpatients of COVID-19 Wijayanto, Masromi Hendria; Tamtomo, Didik; Murti, Bhisma
Indonesian Journal of Medicine Vol. 7 No. 2 (2022)
Publisher : Masters Program in Public Health, Universitas Sebelas Maret, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (31.058 KB)

Abstract

Background: COVID-19 is a common problem in global health. COVID-19 is a disease that infects the respiratory tract caused by the Coronavirus virus. Symptoms range from mild to severe and life-threatening pneumonia can occur. At the beginning of the PSBB, information circulated that Ivemectin could treat COVID-19 infections. Ivermectin is an antiparasitic drug that can be used as prophylaxis and therapy for coronavirus disease 2019. Ivermectin is an alternative therapy for COVID-19 because there is a previous drug, chloroquine, which can be used to treat COVID-19. This study aims to estimate the effectiveness of Ivermectin on the duration of hospitalization of patients with COVID-19 based on the results of previous similar studies.Subjects and Method: This study is a meta-analysis with the following PICO, population: COVID-19 patients. Intervention: ivermectin. Comparison: standard therapy. Outcome: shorter duration of hospital stay. Meta-analyses and systematic studies using the PubMed, Scopus, Scholar, Springlink, Cochrane, Clinical Key, and Science Direct databases. Keywords using Ivermectin AND RCT AND COVID-19 AND “Coronavirus Disease” AND “NCOV disease” AND “COVID-19 treatment”. The article under study is a full-text article with a randomized controlled clinical trial (RCT) study design. Articles were collected using PRISMA diagrams and analyzed using Review Manager 5.3.Results A total of 9 Randomized Control Trial (RCT) studies from Europe, America, Asia and Africa were selected for systematic review and meta-analysis. COVID-19 patients receiving Ivermectin therapy decreased the duration of hospital stay by 1.52 units compared to standard therapy and this result was statistically significant (SMD= -1.52; 95% CI= -2.34 to -0.70; p= 0.003).Conclusion: Ivermectin can reduce the duration of hospital stay for COVID-19 patients.Keywords: COVID-19, ivermectin, duration hospital stayCorrespondence: Masromi Hendria Wijayanto. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Jawa Tengah. Email: masromi­hendria@gmail.com. Mobile: 0895402471549.Indonesian Journal of Medicine (2022), 07(02): 200-208https://doi.org/10.26911/theijmed.2022.07.02.08
Co-Authors Anasulfalah, Hakim Arianty, Meike Bhisma Murti Didik Tamtomo, Didik Husein, Muhammad Fajar Ningsih, Hepti Widia Paramastri, Izdihar Azzah Putra, Muhammad Dudayev Caesar Rohmah, Isna Nur Samudera, Galang Aji Sekar, Fauzia Ichlasul